In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion

We have recently found that allogenic bone marrow transplantation (BMT) can be used to treat lupus nephritis in NZB x NZW F1 (B/W F1) and BXSB mice. To elucidate why and how glomerular damage is repaired, serial renal biopsies were carried out using B/W F1 mice before, and after BMT. Donor-derived B cells and macrophages with normal functions developed two weeks after BMT, whereas donor-derived functional T cells were generated after seven weeks of BMT. Visceral epithelial cells as well as macrophages in the glomeruli were activated (probably by T cell-derived lymphokines) at this time; they showed marked phagocytic activity, resulting in clearance of immune complexes (ICs) and repair of damaged basement membranes. These results suggest that normal T cell functions, which have the capacity to activate macrophages and epithelial cells, are essential in repairing IC-mediated glomerular damage.     

Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice

Previously established dose-response curves indicated that modafinil 20-40 mg/kg i.p. elicited in mice an obvious stimulation of locomotor activity roughly similar to that induced by (+)amphetamine 2-4 mg/kg. The effects of various agents modifying dopamine transmission were compared on the locomotor response to both drugs. The preferential D2 dopamine receptor antagonist haloperidol 37.5-150 micrograms/kg i.p. suppressed the stimulant effect of (+)amphetamine in a dose dependent manner, but not that of modafinil. The D1 dopamine receptor antagonist SCH 23390 (7.5-30 micrograms/kg s.c.) reversed the (+)amphetamine but not the modafinil induced hyperactivity. The tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (200 mg/kg) suppressed the hyperactivity induced by 4 mg/kg dexamphetamine but not that induced by 20 mg/kg modafinil. Associating L-DOPA 150 mg/kg and benserazide 37.5 mg/kg with (+)amphetamine 2 mg/kg resulted in stereotyped climbing behavior, that was not observed with modafinil 10-80 mg/kg. The profound akinesia induced by reserpine (4 mg/kg s.c.; 5 h before testing) was reversed by (+)amphetamine 2 mg/kg but not by modafinil 40 mg/kg. Finally, on synaptosomes prepared from mouse striata preloaded with [3H]dopamine, modafinil 10(-5) M did not increase the spontaneous [3H]dopamine release whereas (+)amphetamine, at the same concentration, doubled it. From all these differences between the two drugs, it is concluded that the mechanism underlying the modafinil induced stimulant locomotor effect differs completely from that of (+)amphetamine.     

Ascorbic acid increases synaptosomal potassium-induced dopamine release

On synaptosomes prepared from striata of mice, increasing concentrations of ascorbic acid (from 0.01 mM to 0.5 mM) did not modify the 3H-dopamine uptake. However, at the 0.1 mM concentration, ascorbic acid increased the potassium-induced release of 3H-dopamine by synaptosomes previously loaded with the amine. This effect was dependent on the presence of Ca2+ in the superfusion medium and was not shared by dehydroascorbic acid (from 1 mM to 0.01 mM). This effect of ascorbic acid, which occurs in the range of its endogenous concentrations, suggests that it is a putative modulator of dopaminergic transmission.     

Propane oxydehydrogenation reaction on a VPO/TiO2 catalyst. Role of the nature of acid sites determined by dynamic in-situ IR studies

A VPO/TiO₂ catalyst tested in the oxydehydrogenation reaction (ODH) of propane between 300 and 400°C shows satisfactory performances (up to 80% of propene selectivity at 2% of propane conversion at 300°C or 56% of propene selectivity at 9% of propane conversion at 400°C). Addition of water or pyridine in the feed gas tends to decrease the propane conversion and enhances the propene selectivity. It is shown that water increases the number of Brönsted surface acid sites by dissociative adsorption which, in turn, enhances propene selectivity at the expense of the CO_x selectivity. These results are in good agreement with spectroscopic IR observations performed under catalytic conditions showing that the Lewis acid sites are linked to CO_xformation, whereas it seems that Brönsted sites would rather be linked to propene formation.     

Bromate Ion Analysis By Ion Chromatography

Bromate ion occurs during ozonation of bromide-containing waters. The current WHO guideline for bromate ion is 25 μg/L. Bromate analysis in drinking waters can be performed by various techniques. However, given the commonly low concentrations of bromate ion found in drinking waters, the classical methods do not fit for bromate analysis in most cases.

A specific conductimetric method with anion suppression which enhances analyte detection by lowering the eluent conductivity is described in this paper for low bromate level analysis. Three eluents have been tested in order to have the best signal to noise ratio. Some other parameters likely to interfere in bromate ion detection (nitrate and sulfate in particular) are also investigated. Taking into account the results of three interlaboratory trials between six European laboratories, a 2 μg/L detection level for bromate can be established.     

Role of the nature of the acid sites in the oxydehydrogenation of propane on a VPO/TiO2 catalyst. An in situ FT-IR spectroscopy investigation

Catalytic activity and surface acidity during the oxydehydrogenation of propane over a VPO/TiO₂ catalyst were determined by a dynamic in situ FT-IR spectroscopy technique at 350°C. Pyridine was used as a probe molecule for the acidity measurements. The obtained results show that propene formation is linked to Brønsted acid sites and that water increases the number of these sites which, in turn, increases propene selectivity.     

A correlation between crystal structure and catalytic activity in the solid solutions CdMoxW1−xO4

Two CdMo_xW_1−xO₄ solid solutions with the scheelite and the wolframite structures were synthesised via different techniques and their structures were determined from powder refinements. The limit of the reciprocal solubility of Mo in CdWO₄ has been checked. Several compositions of the solid solutions have been tested in the catalytic mild oxidation of propane or propene and relations between the structures and the catalytic activity are proposed.     

Identification of the receptor subtype involved in the analgesic effect of neurotensin

The neuropeptide neurotensin (NT) elicits hypothermic and naloxone-insensitive analgesic responses after brain injection. Recent pharmacological evidence obtained with NT agonists and antagonists suggests that these effects are mediated by a receptor distinct from the initially cloned high-affinity NT receptor (NTR1). The recent cloning of a second NT receptor (NTR2) prompted us to evaluate its role in NT-induced analgesia. Intracerebroventricular injections in mice of two different antisense oligodeoxynucleotides from the NTR2 markedly decreased NTR2 mRNA and protein and reduced NT-induced analgesia. This effect was specific, because NTR1 levels were unaffected, and sense or scramble oligodeoxynucleotides had no effect. Structure-activity studies revealed a close correlation between the analgesic potency of NT analogs and their affinity for the NTR2 and disclosed potent and selective agonists of this receptor. These data confirm that NTR1 is involved in the NT-elicited turning behavior and demonstrate that the NTR2 mediates NT-induced analgesia.     

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

Adenosine is released from metabolically active cells by facilitated diffusion, and is generated extracellularly by degradation of released ATP. It is a potent biological mediator that modulates the activity of numerous cell types, including various neuronal populations, platelets, neutrophils and mast cells, and smooth muscle cells in bronchi and vasculature. Most of these effects help to protect cells and tissues during stress conditions such as ischaemia. Adenosine mediates its effects through four receptor subtypes: the A1, A2a, A2b and A3 receptors. The A2a receptor (A2aR) is abundant in basal ganglia, vasculature and platelets, and stimulates adenylyl cyclase. It is a major target of caffeine, the most widely used psychoactive drug. Here we investigate the role of the A2a receptor by disrupting the gene in mice. We found that A2aR-knockout (A2aR-/-) mice were viable and bred normally. Their exploratory activity was reduced, whereas caffeine, which normally stimulates exploratory behaviour, became a depressant of exploratory activity. Knockout animals scored higher in anxiety tests, and male mice were much more aggressive towards intruders. The response of A2aR-/- mice to acute pain stimuli was slower. Blood pressure and heart rate were increased, as well as platelet aggregation. The specific A2a agonist CGS 21680 lost its biological activity in all systems tested.     

From gene to behavior, a new way for elaborating new psychotropic agents

Traditionally, the screening of new neuropsychotropic agents started from the observation of behavioural effects resulting from the administration of a new chemical. Then, one tried to precise its mechanism of action. Since about a decade the way for discovering psychotropic agents tends to be inverse. It starts from the characterization of genes and investigates on their expression products which are new biological targets. Ligands for these targets are developed and then the effects resulting from their administration are considered. In this new strategy, we will consider the cloning of genes and their expression in cultured cells; the knock out of these genes by homologous recombination; the extinction of gene expression by antisense oligodeoxynucleotides; the concentration of behavioural phenotypes by selective breeding.